The ubiquitous Candida spp. is an opportunistic fungal pathogen which, despite treatment
with antifungal drugs, can cause fatal bloodstream infections (BSIs) in immunocompromised …

Medical device-associated infections involve the attachment of cells to a surface, production
of an extracellular matrix and development of a mature biofilm. Many Candida albicans …

As there are sparse data on the impact of growth media on the phenomenon of biofilm
development for Candida we evaluated the efficacy of three culture media on growth …

Dermatophytes are fungi responsible for a disease known as dermatophytosis. Biofilms are
sessile microbial communities surrounded by extracellular polymeric substances (EPS) with …

We have examined the in vitro activities of fluconazole, amphotericin B, and caspofungin
against Candida albicans biofilms by time-kill methodology. Fluconazole was ineffective …

The purpose of this study was to evaluate the effect of eight aerobic and anaerobic oral
commensal bacterial species on in vitro Candida albicans biofilm development. A single …

Candida albicans and Candida glabrata are the two most prevalent etiologic agents of
candidiasis worldwide. Although both are recognized as pathogenic, their choice of …

The most common form of oral candidiasis, denture-associated stomatitis, involves biofilm
growth on an oral prosthetic surface. Cells in this unique environment are equipped to …

Candida albicans has a high propensity to develop biofilms that are resistant to traditional
antifungal agents. Thymol is credited with a series of pharmacological properties including …

Candida spp. proliferate as surface-associated biofilms in a variety of clinical niches. These
biofilms can be extremely difficult to eradicate in healthcare settings. Cells within biofilm …